Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled. https://ift.tt/eA8V8J https://www.nytimes.com

The National Institutes of Health decided to stop one trial because the drug was unlikely to benefit patients, and another because not enough people enrolled.

from NYT > Top Stories https://ift.tt/37MztyB
via IFTTT